Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Molecules ; 23(6)2018 Jun 08.
Artículo en Inglés | MEDLINE | ID: mdl-29890668

RESUMEN

The p53 tumor suppressor plays critical roles in cell cycle regulation and apoptotic cell death in response to various cellular stresses, thereby preventing cancer development. Therefore, the activation of p53 through small molecules is an attractive therapeutic strategy for the treatment of cancers retaining wild-type p53. We used a library of 700 Myanmar wild plant extracts to identify small molecules that induce p53 transcriptional activity. A cell-based screening method with a p53-responsive luciferase-reporter assay system revealed that an ethanol extract of Oroxylum indicum bark increased p53 transcriptional activity. Chrysin was isolated and identified as the active ingredient in the O. indicum bark extract. A treatment with chrysin increased p53 protein expression and the p53-mediated expression of downstream target genes, and decreased cell viability in MCF7 cells, but not in p53-knockdown MCF7 cells. We also found that chrysin activated the ATM-Chk2 pathway in the absence of DNA damage. Hence, the inactivation of the ATM-Chk2 pathway suppressed p53 activation induced by chrysin. These results suggest the potential of chrysin as an anti-cancer drug through the activation of p53 without DNA damage.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Proteínas de la Ataxia Telangiectasia Mutada/metabolismo , Bignoniaceae/química , Quinasa de Punto de Control 2/metabolismo , Flavonoides/farmacología , Proteína p53 Supresora de Tumor/metabolismo , Daño del ADN , Humanos , Células MCF-7 , Extractos Vegetales/farmacología , Transcripción Genética/efectos de los fármacos , Proteína p53 Supresora de Tumor/genética
2.
Biotechnol Bioeng ; 80(7): 755-61, 2002 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-12402321

RESUMEN

A model continuous flow bioreactor (volume 0.5 L) was constructed for removing toxic soluble selenium (selenate/selenite) of high concentrations using a selenate-reducing bacterium, Bacillus sp. SF-1, which transforms selenate into elemental selenium via selenite for anaerobic respiration. Model wastewater contained 41.8 mg-Se/L selenate and excess lactate as the carbon and energy source; the bioreactor was operated as an anoxic, completely mixed chemostat with cell retention time between 2.2-95.2 h. At short cell retention times selenate was removed by the bioreactor, but accumulation of selenite was observed. At long cell retention times soluble selenium, both selenate and selenite, was successfully reduced into nontoxic elemental selenium. A simple mathematical model is proposed to evaluate Se reduction ability of strain SF-1. First-order kinetic constants for selenate and selenite reduction were estimated to be 2.9 x 10(-11) L/cells/h and 5.5 x 10(-13) L/cells/h, respectively. The yield of the bacterial cells by selenate reduction was estimated to be 2.2 x 10(9) cells/mg-Se.


Asunto(s)
Bacillus/metabolismo , Reactores Biológicos , Modelos Biológicos , Compuestos de Selenio/metabolismo , Selenio/metabolismo , Selenito de Sodio/metabolismo , Bacillus/clasificación , Bacillus/crecimiento & desarrollo , Biodegradación Ambiental , Simulación por Computador , Oxidación-Reducción , Proyectos Piloto , Reproducibilidad de los Resultados , Ácido Selénico , Sensibilidad y Especificidad , Especificidad de la Especie , Contaminantes Químicos del Agua/metabolismo , Purificación del Agua/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA